COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,693 Articles (22,913 medRxiv, 8,780 bioRxiv)

Most recent first Previous |  Page 1653: Articles 16521-16530  | Next

Rapid, inexpensive methods for exploring SARS CoV-2 D614G mutation
Al-Jaf, S. M. A., Niranji, S. S., Mahmood, Z. H.
10.1101/2021.04.12.21255337 — Posted: 2021-04-19
Increased Transmissibility of SARS-CoV-2 Lineage B.1.1.7 by Age and Viral Load: Evidence from Danish Households
Lyngse, F. P., Molbak, K., Skov, R. L., Christiansen, L. E., Mortensen, L. H., Albertsen, M. P., Moller, C. H., Krause, T. G., Rasmussen, M., Michaelsen, T. Y., Voldstedlund, M., Fonager, J., Steenhard, N. R., The Danish Covid-19 Genome Consortium, , Kirkeby, C. T.
10.1101/2021.04.16.21255459 — Posted: 2021-04-19
Will the Large-scale Vaccination Succeed in Containing the COVID-19 Epidemic and How Soon?
Zhao, S., Sha, T., Xue, Y., Wu, C.-I., Chen, H.
10.1101/2021.04.16.21255543 — Posted: 2021-04-18
Prevalence and Transmission of SARS-CoV-2 in Childcare Facilities: A Longitudinal Study
Haag, L., Blankenburg, J., Unrath, M., Grabietz, J., Kahre, E., Galow, L., Schneider, J., Dalpke, A., Lueck, C., Buettner, L., Armann, J. P.
10.1101/2021.04.16.21255616 — Posted: 2021-04-18
Adverse effects of COVID-19 vaccination: machine learning and statistical approach to identify and classify incidences of morbidity and post-vaccination reactogenicity
Ahamad, M. M., Aktar, S., Uddin, M. J., Rashed-Al-Mahfuz, M., Azad, A., Uddin, S., Alyami, S. A., Sarker, I. H., Lio, P., Quinn, J. M. W., Moni, M. A.
10.1101/2021.04.16.21255618 — Posted: 2021-04-18
Eating Disorders Spectrum during COVID Pandemic: a systematic review
Miniati, M., Marzetti, F., Palagini, L., Marazziti, D., Orru, G., Conversano, C., Gemignani, A.
10.1101/2021.04.16.21255390 — Posted: 2021-04-18
Enumerating asymptomatic COVID-19 cases and estimating SARS-CoV-2 fecal shedding rates via wastewater-based epidemiology
Schmitz, B. W., Innes, G. K., Prasek, S. M., Betancourt, W. Q., Stark, E. R., Foster, A. R., Abraham, A. G., Gerba, C. P., Pepper, I. L.
10.1101/2021.04.16.21255638 — Posted: 2021-04-18
Expanding access to SARS-CoV-2 IgG and IgM serologic testing using fingerstick whole blood, plasma, and rapid lateral flow assays
Anderson, M. C., Holzmayer, V., Vallari, A., Taylor, R., Moy, J., Cloherty, G.
10.1101/2021.04.16.21255130 — Posted: 2021-04-18
Feasibility and accuracy of a novel saliva sampling method for large-scale SARS-CoV-2 screening in children < 12 years of age
Hoch, M., Vogel, S., Eberle, U., Kolberg, L., Gruenthaler, V., Fingerle, V., Ackermann, N., Sing, A., Liebl, B., Huebner, J., Kuttiadan, S., Rack-Hoch, A., Meyer-Buehn, M., Schober, T., von Both, U.
10.1101/2021.04.17.21255651 — Posted: 2021-04-18
Prospective predictive performance comparison between Clinical Gestalt and validated COVID-19 mortality scores.
Soto-Mota, A., Marfil-Garza, B. A., Castiello, S., Martinez-Rodriguez, E., Carrillo-Vazquez, D., Tadeo Espinoza, H., Guerrero-Cabrera, J. P., Dardon-Fierro, F. E., Escobar Valderrama, J. M., Alanis-Mendizabal, J., Gutierrez-Mejia, J.
10.1101/2021.04.16.21255647 — Posted: 2021-04-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).